Pick your poison
LAA occlusion was noninferior to warfarin for ischemic stroke prevention or SE > 7 days post procedure
PREVAIL trial
Paradoxical to the positive correlation between E/e’ and PCWP, an inverse relationship is found in patients with constriction
- Annulus paradoxus
Unlike other class III agents this AAD increases the defib threshold of AICDs
Amiodarone
This Agatston score can be used to define severe AS in patients with LFLG severe AS with normal LV function
> 2000 in men, > 1300 in women
Dronedarone increased rates of heart failure, stroke, and death from cardiovascular causes in patients with permanent atrial fibrillation who were at risk for major vascular events.
Athena trial
The gold standard for diagnosing myocarditis
Reversal of relationship between lateral and medial e’ velocities in constriction
- Annulus reversus
AAD that increases pacing threshold
Class 1c, flecainide
This Echo scoring system is used to determine the likelihood of success of balloon valvotomy in MS
Wilkins score
In patients with atrial fibrillation, apixaban was superior to warfarin in preventing stroke or systemic embolism, caused less bleeding, and resulted in lower mortality.
Aristotle
In a cohort of patients with ischemic cardiomyopathy, the rates of death from any cause, death from cardiovascular causes, and death from any cause or hospitalization for cardiovascular causes were significantly lower over 10 years among patients who underwent CABG in addition to receiving medical therapy than among those who received medical therapy alone
Stitches Trial
On the heart transplant waiting list, this category of patients have the highest priority
– UNOS status 1A (VAD/2 inotropes + swan + ICU)
Fibrinolytics should be initiated at Non-PCI capable hospital if the estimated medical contact to device time is more than
120 min
Common valve lesion associated with long standing subvalvular aortic stenosis
Aortic valvular regurgitation
Fonadaparinux is similar to enoxaparin in reducing the risk of ischemic events a nighty days but it substantially reduces major bleeding and improves long term mortality and morbidity. However, there was an increased rate of catheter thrombosis.
OASIS – 5 trial
LAA occlusion was noninferior to warfarin for ischemic stroke prevention or SE > 7 days post procedure
PREVAIL trial
Cardiac transplant absolute indication
- Peak Vo2 < 10 - 12 ml/kg/min
Carvedilol reduces the risk of death as well as the risk of hospitalization for cardiovascular causes in patients with systolic heart failure who are receiving treatment for digoxin, diuretics, and an ACE
COPERNICUS trial
Doppler derived gradient across the valve higher than seen in cath lab, seen in small bileaflet prosthetic valves
Pressure recovery phenomenon
In patients with systolic heart failure and a QRS duration of less than 130 msec, CRT does not reduce the rate of death or hospitalization for heart failure and may increase mortality
EchoCRT trial
Beta-blocker therapy, bisoprolol at benefits of survival and stable heart failure patients
CIBIS II trial
Frequency of family screening for HCM in Adults
– 5 years
Drug used to treat Brugada syndrome
Quinidine
Aortic valve severe PPM criteria
iEoA <= 0.65 cm2/m2
For patients with standard indications for ICD therapy, no indication for cardiac pacing, and an LVEF of 40% or less, dual chamber pacing offers no clinical advantage over ventricular back up pacing and may be detrimental by increasing the end points of death or hospitalization for heart failure
DAVID trial